UP TO DATE INFORMATION AND NEWS RELATED TO CANCER RESEARCH AND TREATMENT FOR CANCER PATIENTS AND COMMUNITY.
TRANSLATE
Tuesday, 23 October 2018
Sunday, 14 October 2018
Tuesday, 9 October 2018
Prostate cancer care in elderly men costs Medicare $1.2 billion
The study, published in JAMA
Oncology (Sept. 13, 2018,
was based on an analysis of the Surveillance, Epidemiology, and End Results
(SEER)-Medicare linked database. Looking at the period between 2004 and 2007.
The authors identified nearly 50,000 men who were diagnosed with nonmetastatic
prostate cancer at 70 years of age or older. About half of the patients were 76
years of age or older. While
many patients in the US can’t afford curative cancer treatments, a recent
report has shown that the Medicare is spending a
median of $14,453 per patient within 3 years after the diagnosis of localized
prostate cancer in elderly men. The total Medicare
estimated 3-year costs is $1.2 billion. Localized prostate cancer is a condition that is rarely fatal,
especially in elderly men because localized prostate cancer grows slowly such
that there are higher chances of the patient dying of something else. Therefore,
is questionable the spending of a big amount of taxpayers’ money…. since there
is no prevention of prostate cancer in those patients…
News against the fight of human papillomavirus-induced cancers with the preventive vaccine.
Gardasil 9 (HPV 9-valent Vaccine, Recombinant), a vaccine for the prevention of HPV, has been approved by the FDA for use in males and females aged 9 through 45 years.Gardasil 9 was previously approved by the FDA in 2014 for use in males and females aged 9 through 26 years. The vaccine has been shown to prevent cancers and other diseases caused by the 9 types of HPV: 6, 11, 16, 18, 31, 33, 45, 52, and 58.
Monday, 8 October 2018
Thursday, 4 October 2018
Meta-analysis highlights link between processed meat
and breast cancer
Studies
regarding the link between processed meat and risk of breast cancer have
presented inconsistent results. This problem was addressed by a recently
published meta-analysis in the International Journal of Cancer,
examining 15 studies published on the subject. From this the reviewers
concluded that high processed meat consumption increased the risk of developing
breast cancer by 9%. No significant association was observed between
unprocessed red meat intake and cancer risk.
'Red' meat is
any meat that has a dark red
colour before it is cooked – this includes meats such as beef, lamb and pork. 'Processed' meat is meat that is not sold fresh but has been preserved. For
example, the meat may have been smoked, cured, or had chemical preservatives
added.
Wednesday, 3 October 2018
Subscribe to:
Posts (Atom)